SEC Form 4 research
| Issuer | NEUROCRINE BIOSCIENCES INC |
|---|---|
| Tickers | NBIX |
| Reporting owners | 48 |
| Officers and directors | 26 |
| Last public filing | 2026-09-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-15 | 2026-09-11 | Onyia Jude | A | 3,587 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Lippoldt Darin | A | 4,483 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Keswani Sanjay Chandru | A | 3,914 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | GORMAN KEVIN CHARLES | A | 14,343 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Gano Kyle | A | 1,842 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Gano Kyle | A | 6,275 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Delaet Ingrid | A | 4,483 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Cooke Julie | A | 3,587 | $0 | Not reported |
| 2026-09-15 | 2026-09-14 | Boyer David W. | S | 826 | $157.45 | Not reported |
| 2026-09-15 | 2026-09-11 | Boyer David W. | A | 3,587 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.